Skip to main content
. 2020 Nov 21;12(1):107–119. doi: 10.1007/s13300-020-00954-3

Table 1.

Clinical characteristics, insulin injection habits, and diabetes complications of enrolled subjects according to age class

Patient characteristics, insulin injection habits and complications of diabetes Enrolled subjects (n = 1227) p
Age ≤  65 years Age > 65 years
Clinical characteristics
 Subjects, n (%) 817 (67) 410 (33) 0.001
 Male gender, n (%) 327 (40) 97 (23) 0.05
 Mean age (years) 53 ± 13 73 ± 8 0.01
 Body mass index (kg/m2) 31 ± 5 27 ± 6 0.05
 HbA1c (%) 8.1 ± 1.2 8.9 ± 1.4 0.05
 Since DM diagnosis (years) 9 ± 7 12 ± 9 0.05
 Duration of insulin treatment (years) 8 ± 4 12 ± 5 0.01
 Daily insulin dose requirement (IU/day) 49 ± 15 43 ± 11 0.01
 Subjects with HEs, n (%) 418 (51) 268 (65) 0.01
 Glycemic variability (mg/dl) 281 ± 62 347 ± 69 0.001
 Lipohypertrophy, n (%) 396 (48) 322 (79) 0.001
Injection habits, n (%)
 Needle reuse 495 (61) 267 (65) n.s.
 Failure to rotate injection sites 397 (49) 189 (46) n.s.
 Ice-cold insulin injection 411 (51) 201 (49) n.s.
 Suitable post-injection needle removal lag 74 (9) 25 (6) n.s.
 Post-injection leakage of insulin from the injection site (drop-leaking) 319 (39) 193 (47) 0.05
 Painful injection 131 (16) 21 (5) 0.01
 Injection into LH nodules 383 (47) 310 (56) 0.05
Diabetes complications, n (%)
 Cardio-/cerebro-vascular disease 180 (22) 144 (35) 0.01
 Lower limb complications 65 (8) 111 (27) 0.01
 Retinopathy 172 (21) 207 (49) 0.01
 Nephropathy/dialysis 229 (28) 213 (52) 0.01
 Sensory-motor neuropathy 139 (17) 164 (40) 0.01
 Autonomic neuropathy 90 (11) 131 (32) 0.01

Data in table are presented as the mean ± standard deviation (SD) or as a number with the percentage in parentheses

DM Diabetes mellitus, HbA1c glycated hemoglobin, HE hypoglycemic episode, LH lipohypertropy, n.s. not significant